In a Year Dominated by the Global COVID Pandemic, The Institute Kept Moving Forward
LOS ANGELES — The Lundquist Institute, a world leader in biomedical research, today released its 2020 Year in Review video. 2020 was an unparalleled year and given the challenge of working against the backdrop of the global COVID pandemic, the Institute had one of its most outstanding years ever.
California Institute for Regenerative Medicine (CIRM) Funds New Research on Nanotechnology for Stem Cell Implantation and Diabetes Treatment
LOS ANGELES — Two junior Investigators at the The Lundquist Institute, Dr. Eiji Yoshihara and Dr. Lina R. Nih, have received a Quest Award from the California Institute for Regenerative Medicine (CIRM). The Quest Award is for discovery research and aims to promote promising new technologies that could be translated for broad use and improved patient care.
First phase of plan includes up to 250,000 square feet of lab, manufacturing and office space
LOS ANGELES – The Lundquist Institute received unanimous approval from the Los Angeles County Board of Supervisors to begin development of a 15-acre biotech park, which will serve as a hub and catalyst for the region’s rapidly-developing bioscience industry.
Dr. Richard Casaburi is a world-renowned expert on COPD
LOS ANGELES – The Lundquist Institute investigator, Richard Casaburi, PhD, MD, has been presented with the European Respiratory Society’s (ERS) most prestigious honor, the Presidential Award, in recognition of his outstanding work to strengthen respiratory science and medicine worldwide. The award was presented during the ERS annual International Congress 2020 that welcomed more than 33,000 virtual attendees from around the world.
Second Live Virtual Webinar — COVID-19: Pregnancy, Infants & Children on Sept. 30 at 6pm PDT
LOS ANGELES — The Lundquist Institute has announced the second in its new series of online webinars, “The Lundquist Community Science Series.” This community service webinar series features internationally-renowned Lundquist investigators and clinician scientists, who will be addressing timely topics in areas of biomedical research and healthcare on a regular basis.
First participants received the shot at The Lundquist Institute on Friday, September 4; more injections scheduled next week
LOS ANGELES – The Lundquist Institute at Harbor-UCLA Medical Center officially began phase 3 trials of the Oxford University – AstraZeneca COVID-19 vaccine trial on Friday, September 4.
Matthew Budoff, MD presented the EVAPORATE results at the ESC Congress 2020 on August 29, 2020, with concurrent publication in the European Heart Journal
LOS ANGELES — Today, The Lundquist Institute announced that Matthew Budoff, MD, Director of Cardiovascular CT at the Institute and Professor of Medicine at the David Geffen School of Medicine at UCLA, will present the final results of the EVAPORATE study at ESC Congress 2020 (organized by the European Society of Cardiology) with concurrent publication in the European Heart Journal.
Institute hosts commencement ceremony for first-ever virtual lecture series curriculum bringing together students with world renowned scientists
LOS ANGELES — The Lundquist Institute hosted the commencement ceremony for 82 high school students graduating from its Summer Fellows Program 2020, an eight-week course of study designed to encourage graduating high school seniors and high school juniors to explore careers in the field of biomedical science.
Study will allow The Lundquist Institute to determine the multi-generational risks of developing asthma from vaping while pregnant
LOS ANGELES - Studies have shown that pregnant women who smoke increase the risk of their children having asthma, and that those children—even if non-smokers—can pass it on to their own children, but few objective studies have evaluated the effects of vaporized nicotine and vapor flavorings. Investigators from The Lundquist Institute, under the leadership of Virender Rehan, MD, have received a $2.3 million grant from the National Institutes of Health (NIH) to research this multi-generational effect of vaping, or smoking an electronic cigarette, while pregnant.
New Long-Term Follow-Up Study Published Today in JAMA (Journal of the American Medical Association) Shows Noteworthy Results
LOS ANGELES - The Lundquist Institute announced today a new study published in JAMA (Journal of the American Medical Association) which examined the link between hormonal therapy, particularly estrogen and progestin, and the incidence of breast cancer mortality. The team found that the use of estrogen alone among women who had a prior hysterectomy resulted in a lower rate of breast cancer incidence and mortality.